This research highlights two decades of trends in treatment admissions for cannabis use disorder (CUD) among pregnant women in the U.S. Using national treatment episode data from 2000 to 2021, the study shows that admissions for CUD have fluctuated significantly, with notable differences by age and race/ethnicity. While admissions peaked in 2018, they declined in recent years—possibly reflecting shifts in public attitudes, access to treatment, and the normalization of cannabis use. The study also underscores the high prevalence of co-substance use, suggesting that cannabis use during pregnancy often occurs within a broader pattern of polysubstance use.
Reflection for Facilitators
This research reinforces the importance of our role in providing clear, accurate information about FASD and its prevention. As cannabis use becomes more normalized—especially during pregnancy—our conversations help bridge the gap between perception and evidence. Many people are unaware of the potential impacts of cannabis on fetal development or may view it as a safe option for managing symptoms.
The study also reminds us that substance use in pregnancy is complex and often shaped by broader social and health factors. Our approach must remain supportive and non-judgmental, creating safe spaces for learning and dialogue. Prevention starts with awareness—and facilitators play a vital role in ensuring that individuals, families, and communities are informed, respected, and empowered to make healthy choices.